I am a
Home I AM A Search Login

Papers of the Week

Papers: 7 May 2022 - 13 May 2022


2022 May 11

Dermatol Ther (Heidelb)

Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset.


Eichenfield LF, Armstrong A, Guttman-Yassky E, Lio PA, Chen C-C, Hines DM, McGuiness CB, Ganguli S, Delevry D, Sierka D, Mallya UG
Dermatol Ther (Heidelb). 2022 May 11.
PMID: 35543920.


While the efficacy of dupilumab for the treatment of adults with moderate-to-severe atopic dermatitis (AD) has been demonstrated in several clinical trials, patients in such trials may not necessarily reflect the real-world clinical practice setting. This study evaluated the real-world effectiveness of dupilumab in adults with moderate-to-severe AD based on physician global assessment, percent body surface area affected, and patient-reported itch.